A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen

Background. Long-lasting protection resulting from hepatitis B vaccine, despite loss of antibody against hepatitis B virus (HBV) surface antigen (anti-HBs), is undetermined. Methods. We recruited persons from a cohort vaccinated with plasma-derived hepatitis B vaccine in 1981 who have been followed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Infect Dis
Asıl Yazarlar: Simons, Brenna C., Spradling, Philip R., Bruden, Dana J. T., Zanis, Carolyn, Case, Samantha, Choromanski, Tammy L., Apodaca, Minjun, Brogdon, Hazel D., Dwyer, Gaelen, Snowball, Mary, Negus, Susan, Bruce, Michael G., Morishima, Chihiro, Knall, Cindy, McMahon, Brian J.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2016
Konular:
Major Articles and Brief Reports
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4918827/
https://ncbi.nlm.nih.gov/pubmed/27056956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw142
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller